Official UK procurement notice
Procurement for Services related to COVID-19
Authority: Office for National Statistics (Central government)
What is being bought
Published requirement descriptionThe Office for National Statistics ('ONS') has a requirement to procure Services related to COVID-19. ONS was commissioned in April 2020 to conduct the COVID-19 Infection Survey collecting the data which informs HMG's policies and operational interventions regarding the COVID-19 pandemic. CIS is a repeated cross-sectional household survey with additional serial sampling and longitudinal follow-up which provides an estimate of the proportion and number of people living in private households who would have had COVID-19 in the last week based on trend modelling. The study is led by DHSC and ONS and draws on the world-leading scientific expertise of the University of Oxford. CIS is the flagship surveillance study and the key source of COVID-19 infection data, incidence and antibody prevalence in UK communities. We work with key stakeholder partners; PHE, PHS, PHW, the Joint Biosecurity Centre, Ministers, SAGE, and the wider UK Test & Trace programmes to inform required policy and operational interventions.
CPV: Data-processing services · Freight transport agency services · Human resources management consultancy services · Recruitment services · Research and development services and related consultancy services · Services provided by medical personnel · Storage and warehousing services · Survey analysis services · Survey design services · Survey services · Telephone survey services
The lotProcurement structure
single lot · value publishedLot #1The Authority requires a Prime Provider to supply and manage an integrated service for…RenewalPublished value£1,100,000,000
The Authority requires a Prime Provider to supply and manage an integrated service for the CIS to households in England, Wales, Scotland and Northern Ireland to be made up of the Services listed below:
- Supply and integration of Study Workers to conduct fieldwork and their management, including the provision of trained phlebotomists
- The provision of data and Management Information
- Contact Centre
- Courier, Logistics and Warehousing
- Future Requirements as Options within the Contract
- The Provider, across the service and integration, will play a pivotal role in delivering the established survey activities but will also be required to adapt and be flexible in the way these are delivered. The pace and scale of change is not predictable, given the unprecedented nature, and hence the data required to support the response to the COVID-19 pandemic. The Provider's ability and contributions will be fundamental to support this.
Supply and Integration of Study Workers to Conduct Fieldwork and their Management - Overview
The Authority has a requirement for the delivery of all operational aspects of UK fieldwork for The Authority's COVID-19 Infection Survey throughout the period June 2021-March 2023. This will include overall responsibility of integration of all services, provision of underlying data infrastructure and data flows.
This shall include full survey and fieldwork management, including preparation of training material, recruitment of Study Workers who support participant self-administration of swabs, recruitment of phlebotomists as Study Workers for the collection of venous blood samples and to support participant self-administration of swabs, training and management of the Study Workers, provision of appointment scheduling, supply chain management, venous blood and swab sample management system, end-to-end data flow management, quality assurance, collation of management information, managing and resolving complaints and incident resolution, information security and overall service integration. With the health and safety of participants and staff the highest priority, of particular note is that this includes a key role leading a 'health and safety first' culture across the field operation.
The fieldwork shall cover England, Wales, Scotland and Northern Ireland and be adaptive to survey sample requirements. The anticipated field force size will need to be able to deliver circa 130,000 unique tests per week, to include study workers and trained phlebotomists. The Field Force will follow NHS guidance regarding protective equipment. The study parameters are estimated, and these may change due to epidemiological requirements. All parameters and study design are subject to medical ethics approval.
The survey is a large-scale operation and success depends on the ability to successfully align data collection resources to meet the participant testing requirement, completing the data collection to a high standard and ensuring both a high-quality respondent experience and integrity in the data flows that occur. The study shall recruit on average approximately 35,000 participants per month throughout the period until March 2023. During this time, the number of active participants will typically be approximately 450,000, although the study will only be testing at peak effort approximately 130,000 a week. All participants shall be swab tested and up to 20 % of participants shall also receive blood tests for antibodies. The number of Study Worker visits shall therefore scale accordingly based on an average household size of approximately 2 participants.
Contact Centre - Overview
The fieldwork shall be supported by a participant Contact Centre to assist with registration, data collection, complaints handling, queries and potential assisted digital completion support. Service is required 7 days a week and operate the following hours:
- Monday-Thursday - 9am-9pm
- Friday - 9am-8pm
- Saturday-Sunday - 9am-5pm
The current level of resource is around 150 full-time equivalent staff. The service must be able to flex to meet study demands.
Courier, Logistics and warehousing - Overview
The Supplier shall provide a courier, logistics and warehousing service to support the fieldwork, to arrange distribution of equipment from warehousing to field staff, and movement of biological material from the Field Workers to around 100 UK-wide local collection points, to the selected UK testing centres (lighthouse labs currently at Glasgow, Milton Keynes and Oxford) within 24-48 hours of collection, warehousing and picking and packing service for interviewer kits (estimated at 4000-7000 parcels a week) which will include swabs, PPE, testing equipment and other survey materials for supply through the duration of the study. The estimated storage space per month is between 250 and 350 pallets.
Options - Overview
The Authority has two potential future requirements that it would like the Tenderers to consider *:
- For the provision of an online data capture platform in order to facilitate online participant registration, consent, assent and interviews, which will be expected to allow around 100,000 individual completions per week across the whole of the UK and be integrated into the operational model.
- For the replacement of venous blood draw with capillary (finger prick) blood draw.
- Note that these will not form part of the tender evaluation
Medical Protocol Dependencies
The CIS is a medical research study which takes biological samples from participants and therefore falls under the remit of the Human Tissue Act. As such, it operates under a strict medical ethics Protocol, which details exactly how the research must be conducted and requires formal approval from an NHS Research Ethics Committee and also a study Sponsor, Oxford University. Any change to supplier or design must be agreed in advance and then approved by the Research Ethics Committee. This must be carried out before conducting …
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (3)
- Programme/Quality: 30%
- Technical: 40%
- Commercial: 30%
Published award criteria (3)
- Programme/Quality: 30%
- Technical: 40%
- Commercial: 30%
- Suitability
The Authority has a mandatory requirement for Tenderers to be able to demonstrate experience of implementing large scale (with participants to the order of 1000s) clinical research to Good Clinical Practice (GCP) standard, including compliance with requirements for material considered relevant under the Human Tissue Act and special category data under UK GDPR.
- Price carries 30 of 100 points: a 10% discount moves about 3 points. The method statement decides this lot, not the discount.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 22 Jan 2021, 11:10 GMT
- Last source update
- 27 Jul 2021, 18:14 BST
- Award evaluation window
- 25 Feb 2021 – …
- Authority reference
PU-21-0140- FTS notice number
2021/S 000-001035- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-028b61Find a Tender
Publisher note: The requirement specified within the ITT may be subject to change during the procurement process at the Authority's discretion. The Authority shall ensure it undertakes an evaluation on a fair, open and transparent basis in line with the Public Contracts Regulations 2015. There is a requirement for Tenderers to register on the e-sourcing platform (Intend) prior to securing access to the ITT.
How it was run
Official noticeTender documents are also served through a separate tool: https://in-tendhost.co.uk/ons/aspx/Home ↗
- Submission deadline
- 24 Feb 2021, 13:00 GMT
- Submission channel
- {"written"}
- Accepted languages
- en
- Bids opened
- 25 Feb 2021
Timeline
24 Feb 2021 → 27 Jul 2021 · 3 dates- Submission deadline24 Feb 2021, 13:00 GMT
- Bids opened25 Feb 2021
- Notice published27 Jul 2021, 18:14 BST
Notice history
5 events · 4 releases on Find a Tender · since 6 Jul 2021- Status changed to complete6 Jul 2021, 12:37 BST
- Procurement method changed6 Jul 2021, 12:37 BST
- Published value published: £1,100,000,00027 Jul 2021, 18:14 BST
- Status changed to active27 Jul 2021, 18:14 BST
- Deadline moved to 24 Feb 2021, 13:00 GMT27 Jul 2021, 18:14 BST-2 days · was 26 Feb 2021, 12:00 GMT
Published amendments (2 · 2 deadline changes)
| When | What | Before | After | Shift |
|---|---|---|---|---|
| — | DeadlineIV.2.2 | 24 Feb 2021 | 26 Feb 2021 | +2 d |
| — | Bid openingIV.2.7 | 25 Feb 2021 | 27 Feb 2021 | +2 d |
| — | DeadlineIV.2.2 | 24 Feb 2021 | 1 Mar 2021 | +5 d |
| — | Bid openingIV.2.7 | 25 Feb 2021 | 2 Mar 2021 | +5 d |
In addition to the change in time limit for requests to participate, the Invitation to Tender will now be published on 27 January 2021 at 12:00 hours.
This Corrigendum Notice supersedes the Corrigendum Notice published on 22 January 2021 (Publication reference: 2021/S 000-001312). In addition to the change in time limit for requests to participate, the Invitation to Tender will now be published on 29 January 2021 at 12:00 hours. The time limit for receipt of requests to participate will now be 1 March 2021 at 12:00 hours.
Routine re-releases (4)
- 2021-01: 1 release · 22 Jan 2021
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| IQVIA LtdServices Related to Covid-19 | £710,000,000 † | — | Awarded |
Contracts
Services Related to Covid-19 · IQVIA Ltd
- Signed
- 28 May 2021
- Value
- £710,000,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 2bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- High Court of England and WalesReview body
Bidders & participating suppliers
1 commercial party on the notice- IQVIA LimitedAwarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria